Search for: "Paddock Laboratories, Inc."
Results 1 - 4 of 4
Sorted by Relevance | Sort by Date
RSS Subscribe:  20 results  |  100 results
28 Aug 8:11 am by Karen E. Keller
... v. Microsoft Corporation, Intel Corporation, Marvell Technology Group Ltd., Marvell Semiconductor Inc., Hewlett Packard Co., et al. (patent infringement) 8/21: LadaTech LLC ... Packard Company, AstraZeneca Pharmaceuticals LP, Dow Chemical Company, Advanced Micro Devices, Inc., Dreamworks Animation SKG, et al. (patent infringement) 8/26: Evonik ... , Napp Pharmaceutical Group Ltd., Ortho-McNeil-Janssen Pharmaceuticals Inc. v. Paddock Laboratories Inc. (patent infringement) 9/9: Andrew LLC v. TruePosition ...
Delaware IP Law Blog - http://www.delawareiplaw.com/
22 Jun 12:23 am by The Docket Navigator
... controversy. Thus, [the third-party plaintiff's] broad claims that the [third-party defendant's New Drug Application] and the listing of the [patent-in-suit] adversely affected its ability to market [its product] do not give rise to a justiciable controversy." Galderma Laboratories, LP et al v. Paddock Laboratories Inc., 4-09-cv-00002 (TXND June 18, 2009, Order) (Means, J.)
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
12 Oct, 2007 10:31 am by Bill Heinze
In Schwarz Pharma, Inc., et al v. Paddock Laboratories, Inc. (October 12, 2007), the Federal Circuit was not persuaded that, for claims to "A pharmaceutical composition. . ." and "A process for stabilizing an ACE inhibitor drug against cyclization which comprises the step of contacting the drug with . . .", MgO had to have been known as a stabilizer against the specific degradation pathway of cyclization or for the specific drug category of ACE ...
I/P Updates - http://ip-updates.blogspot.com
6 Mar 7:03 am
... industry, Fed. Trade Comm'n et al. v. Watson Pharm., Inc. et al., 09-cv-00598 (AHM) ("Watson"). In a press release announcing ... also names generic pharmaceutical companies Watson Pharmaceuticals, Par Pharmaceuticals and Paddock Laboratories. Pursuant to the regulatory framework of the Drug Price Competition and Patent Term ... pharmaceutical companies to invest in developing new drugs. The ANDAs filed by Watson and Paddock certified that Solvay's patent was either invalid or not infringed, and sought ...
Antitrust Law Blog - http://www.antitrustlawblog.com/
         
Add to your RSS Reader Add to your Google Add to your My Yahoo Add to your My MSN Add to your My AOL Add to your Feedster Add to your Newsgator Add to your Bloglines Add to your NewsBurst Add to your Rojo Add to your Pluck